UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported):  October 15, 2007

 

Merit Medical Systems, Inc.

(Exact name of registrant as specified in its charter)

 

Utah

 

0-18592

 

87-0447695

(State or other jurisdiction of

 

(Commission

 

(I.R.S. Employer

incorporation or organization)

 

File Number)

 

Identification No.)

 

1600 West Merit Parkway

 

 

South Jordan, Utah

 

84095

(Address of principal executive offices)

 

(Zip Code)

 

(801) 253-1600

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

 

ITEM 7.01             REGULATION FD DISCLOSURE.

 

On October 15, 2007, Merit Medical Systems, Inc. (the “Company”) issued a press release entitled “Merit Medical Announces Improvement in Gross Margins and Profits and Conference Call Information for 3Q 2007.”

 

The press release issued on October 15, 2007 is furnished as Exhibit No. 99.1 to this Current Report on Form 8-K. The Company’s periodic reports on Forms 10-K, 10-Q and 8-K, and other publicly available information, should be consulted for other important information about the Company.

 

The information in this Report, including Exhibit No. 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section. The information in this Report shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

 

ITEM 9.01             FINANCIAL STATEMENTS AND EXHIBITS.

 

(d)         Exhibits.

 

Exhibit
Number

 

Title of Document

 

Location

 

 

 

 

 

99.1

 

Press Release, dated October 15, 2007, entitled “Merit Medical Announces Improvement in Gross Margins and Profits and Conference Call Information for 3Q 2007.”

 

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

MERIT MEDICAL SYSTEMS, INC.

 

 

 

 

Date: October 15, 2007

By:

 /s/ Kent W. Stanger

 

 

Chief Financial Officer, Secretary
and Treasurer

 

3



 

EXHIBIT INDEX

 

EXHIBIT
NUMBER

 


DESCRIPTION

 

 

 

99.1

 

Press Release, dated October 15, 2007, entitled “Merit Medical Announces Improvement in Gross Margins and Profits and Conference Call Information for 3Q 2007.”

 

4